Revive Therapeutics Receives Receipt for Final Short-Form Prospectus for Previously Announced $20 Million Bought Deal Public Offering

Feb 9, 2021

TORONTO, Feb. 09, 2021 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV) (USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that,...

PharmaDrug Signs Supply Agreement with Global Cannabis Supplier and Provides Update on German Operations and Balance Sheet Improvements

Feb 4, 2021

Toronto, Ontario – February 4, 2021 – PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company”) has entered into a supply agreement (the “Supply Agreement”) on January 4, 2021, with a Canadian based...

PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc.

Feb 2, 2021

Toronto, Ontario – February 2, 2021  – PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and...

Revive Therapeutics Announces Upsize to Previously Announced Bought Deal Offering

Jan 21, 2021

TORONTO, Jan. 21, 2021  – Revive Therapeutics Ltd. (“Revive” or the “Company“) (CSE:RVV) (USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has...

Revive Therapeutics Announces $10 Million Bought Deal Offering of Units

Jan 20, 2021

TORONTO, Jan. 20, 2021 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV) (USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is...

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders

Jan 19, 2021

TORONTO, Jan. 19, 2021 – Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psychedelic...